skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 32  for All Library Resources

Results 1 2 next page
Refined by: Database: Coronavirus Research Database remove Journal Title: Vaccines remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis
Material Type:
Article
Add to My Research

Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis

Vaccines (Basel), 2022-06, Vol.10 (7), p.1049 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10071049 ;PMID: 35891214

Full text available

2
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
Material Type:
Article
Add to My Research

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer

Vaccines (Basel), 2021-11, Vol.9 (12), p.1413 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121413 ;PMID: 34960159

Full text available

3
Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review
Material Type:
Article
Add to My Research

Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review

Vaccines (Basel), 2022-08, Vol.10 (8), p.1349 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the author. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10081349 ;PMID: 36016237

Full text available

4
Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Material Type:
Article
Add to My Research

Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Vaccines (Basel), 2022-10, Vol.10 (10), p.1702 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10101702

Full text available

5
COVID-19 in Low- and Middle-Income Countries (LMICs): A Narrative Review from Prevention to Vaccination Strategy
Material Type:
Article
Add to My Research

COVID-19 in Low- and Middle-Income Countries (LMICs): A Narrative Review from Prevention to Vaccination Strategy

Vaccines (Basel), 2021-12, Vol.9 (12), p.1477 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121477 ;PMID: 34960223

Full text available

6
Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
Material Type:
Article
Add to My Research

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance

Vaccines (Basel), 2021-04, Vol.9 (5), p.420 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050420 ;PMID: 33922273

Full text available

7
Distinct Adverse Reactions to mRNA, Inactivated Virus, and Adenovirus Vector COVID-19 Vaccines: Insights from a Cohort Study on Atopic and Non-Atopic Subjects in Brazil
Material Type:
Article
Add to My Research

Distinct Adverse Reactions to mRNA, Inactivated Virus, and Adenovirus Vector COVID-19 Vaccines: Insights from a Cohort Study on Atopic and Non-Atopic Subjects in Brazil

Vaccines (Basel), 2024-04, Vol.12 (4), p.408 [Peer Reviewed Journal]

2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12040408 ;PMID: 38675790

Full text available

8
High COVID-19 Vaccine Acceptance among Eye Healthcare Workers in Uganda
Material Type:
Article
Add to My Research

High COVID-19 Vaccine Acceptance among Eye Healthcare Workers in Uganda

Vaccines (Basel), 2022-04, Vol.10 (4), p.609 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10040609 ;PMID: 35455358

Full text available

9
Global Disparities in Access to Vaccine Clinical Trials: A Review of the Literature
Material Type:
Article
Add to My Research

Global Disparities in Access to Vaccine Clinical Trials: A Review of the Literature

Vaccines (Basel), 2024-03, Vol.12 (4), p.348 [Peer Reviewed Journal]

2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12040348 ;PMID: 38675731

Full text available

10
The Coverage and Acceptance Spectrum of COVID-19 Vaccines among Healthcare Professionals in Western Tanzania: What Can We Learn from This Pandemic?
Material Type:
Article
Add to My Research

The Coverage and Acceptance Spectrum of COVID-19 Vaccines among Healthcare Professionals in Western Tanzania: What Can We Learn from This Pandemic?

Vaccines (Basel), 2022-08, Vol.10 (9), p.1429 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10091429 ;PMID: 36146507

Full text available

11
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Material Type:
Article
Add to My Research

Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness

Vaccines (Basel), 2023-08, Vol.11 (8), p.1347 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11081347 ;PMID: 37631915

Full text available

12
The Race for COVID-19 Vaccines: Accelerating Innovation, Fair Allocation and Distribution
Material Type:
Article
Add to My Research

The Race for COVID-19 Vaccines: Accelerating Innovation, Fair Allocation and Distribution

Vaccines (Basel), 2022-09, Vol.10 (9), p.1450 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10091450 ;PMID: 36146528

Full text available

13
Frontiers in Shigella Vaccine Development
Material Type:
Article
Add to My Research

Frontiers in Shigella Vaccine Development

Vaccines (Basel), 2022-09, Vol.10 (9), p.1536 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10091536 ;PMID: 36146614

Full text available

14
Comparison of COVID-19 Vaccine Policies in Italy, India, and South Africa
Material Type:
Article
Add to My Research

Comparison of COVID-19 Vaccine Policies in Italy, India, and South Africa

Vaccines (Basel), 2022-09, Vol.10 (9), p.1554 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10091554 ;PMID: 36146632

Full text available

15
Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines
Material Type:
Article
Add to My Research

Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines

Vaccines (Basel), 2022-08, Vol.10 (8), p.1320 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10081320 ;PMID: 36016208

Full text available

16
A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda
Material Type:
Article
Add to My Research

A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda

Vaccines (Basel), 2021-03, Vol.9 (3), p.253 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9030253 ;PMID: 33809269

Full text available

17
Geospatial and Time Trend of Prevalence and Characteristics of Zero-Dose Children in Nigeria from 2003 to 2018
Material Type:
Article
Add to My Research

Geospatial and Time Trend of Prevalence and Characteristics of Zero-Dose Children in Nigeria from 2003 to 2018

Vaccines (Basel), 2022-09, Vol.10 (9), p.1556 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the author. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10091556 ;PMID: 36146634

Full text available

18
COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing
Material Type:
Article
Add to My Research

COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing

Vaccines (Basel), 2022-04, Vol.10 (4), p.594 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10040594 ;PMID: 35455343

Full text available

19
Towards Improved Use of Vaccination in the Control of Infectious Bronchitis and Newcastle Disease in Poultry: Understanding the Immunological Mechanisms
Material Type:
Article
Add to My Research

Towards Improved Use of Vaccination in the Control of Infectious Bronchitis and Newcastle Disease in Poultry: Understanding the Immunological Mechanisms

Vaccines (Basel), 2021-01, Vol.9 (1), p.20 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9010020 ;PMID: 33406695

Full text available

20
Optimising COVID-19 Vaccination Policy to Mitigate SARS-CoV-2 Transmission within Schools in Zimbabwe
Material Type:
Article
Add to My Research

Optimising COVID-19 Vaccination Policy to Mitigate SARS-CoV-2 Transmission within Schools in Zimbabwe

Vaccines (Basel), 2021-12, Vol.9 (12), p.1481 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121481 ;PMID: 34960227

Full text available

Results 1 - 20 of 32  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait